[Granulosa cell tumors of the ovary].
Ovarian granulosa cell tumors (TGO) are rare neoplasms. They arise from sex cord stromal cells of the ovaries. They are characterized by their slow natural history, and their tendency to relapse long time after the initial diagnosis. Complete staging surgery of the disease is the cornerstone of treatment. Chemotherapy is indicated for localized tumors with a high risk of recurrence, and for recurrent or advanced tumors. Prolonged follow-up is recommended.
Institut national d'oncologie, service d'oncologie médicale, avenue Allal el fassi, BP 10100, Rabat, Maroc.
Sakina
S
Sekkate
Institut national d'oncologie, service d'oncologie médicale, avenue Allal el fassi, BP 10100, Rabat, Maroc.
Mouna
M
Kairouani
Hôpital IBN SINA, service de chirurgie « A », Rabat, Maroc.
Badr
B
Serji
Institut national d'oncologie, service d'oncologie médicale, avenue Allal el fassi, BP 10100, Rabat, Maroc.
Hind
H
M'Rabti
Institut national d'oncologie, service d'oncologie médicale, avenue Allal el fassi, BP 10100, Rabat, Maroc.
Ibrahim
I
El Ghissassi
Institut national d'oncologie, service d'oncologie médicale, avenue Allal el fassi, BP 10100, Rabat, Maroc.
Hassan
H
Errihani
D000367:Age Factors; D000970:Antineoplastic Agents / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000378:metabolism; D003937:Diagnosis, Differential; D005260:Female; D006106:Granulosa Cell Tumor / Q000235:genetics / Q000473:pathology / Q000532:radiotherapy / Q000628:therapy; D006801:Humans; D058990:Molecular Targeted Therapy / Q000379:methods; D035583:Rare Diseases / Q000473:pathology / Q000628:therapy
D000970:Antineoplastic Agents; D018931:Antineoplastic Agents, Hormonal; D014408:Biomarkers, Tumor
cancer; chemotherapy; granulosa cell tumors; ovary; prognosis; surgery